Benign Prostatic Hyperplasia Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Benign Prostatic Hyperplasia stocks.

Benign Prostatic Hyperplasia Stocks Recent News

Date Stock Title
Jul 3 LLY Lilly's new Alzheimer's drug could generate $7.1B in sales: analyst
Jul 3 LLY S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
Jul 3 LLY Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
Jul 3 LLY Weight-loss drugs linked to rare vision loss: Harvard study
Jul 3 LLY ADP jobs data, Constellation Brands, summer gas prices: Morning Brief
Jul 3 LLY Ozempic Linked to Rare Cases of Vision Loss in Harvard Study
Jul 3 LLY FDA Approves Eli Lilly's Alzheimer's Drug Kisunla
Jul 3 BSX Artisan Global Discovery Fund Trimmed Boston Scientific Corporation (BSX) for Valuation Discipline
Jul 3 LLY Top 3 Health Care Stocks That May Crash This Quarter
Jul 3 LLY Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Jul 3 LLY 5 Things to Know Before the Stock Market Opens
Jul 3 LLY Eli Lilly Advances Alzheimer's Solutions With Kisunla Approval
Jul 3 LLY Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
Jul 3 LLY Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today
Jul 2 LLY Boeing, Tesla stock reaction, small-cap portfolio: Market Domination
Jul 2 LLY Eli Lilly’s donanemab wins FDA approval for Alzheimer’s disease
Jul 2 LLY Novo Nordisk and Eli Lilly Slide as Biden Blasts Weight-Loss Drug Prices
Jul 2 LLY Alzheimer’s Disease Treatments: What to Know About New and Future Drugs
Jul 2 LLY Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug
Jul 2 LLY Eli Lilly Gets FDA Approval for Alzheimer's Disease Drug
Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH), also called prostate enlargement, is a noncancerous increase in size of the prostate. Symptoms may include frequent urination, trouble starting to urinate, weak stream, inability to urinate, or loss of bladder control. Complications can include urinary tract infections, bladder stones, and chronic kidney problems.The cause is unclear. Risk factors include a family history, obesity, type 2 diabetes, not enough exercise, and erectile dysfunction. Medications like pseudoephedrine, anticholinergics, and calcium channel blockers may worsen symptoms. The underlying mechanism involves the prostate pressing on the urethra thereby making it difficult to pass urine out of the bladder. Diagnosis is typically based on symptoms and examination after ruling out other possible causes.Treatment options including lifestyle changes, medications, a number of procedures, and surgery. In those with mild symptoms weight loss, exercise, and decreasing caffeine intake is recommended. In those with more significant symptoms medications may include alpha blockers such as terazosin or 5α-reductase inhibitors such as finasteride. Surgical removal of part of the prostate may be carried out in those who do not improve with other measures. Alternative medicine, such as saw palmetto, does not appear to help.About 105 million people are affected globally. BPH typically begins after the age of 40. Half of males age 50 and over are affected. After the age of 80 about 90% of males are affected. Although prostate specific antigen levels may be elevated in males with BPH, the condition does not increase the risk of prostate cancer.

Browse All Tags